Publications by authors named "G Perrenoud"
Article Synopsis
- * Researchers conducted a chart review of 149 patients who died in 2011 or 2012, revealing that most died in intensive care, often after withdrawing life-sustaining treatment, with significant reliance on invasive interventions and medications.
- * Findings highlighted varied symptom prevalence among diagnostic groups and showed that while many patients stayed in hospitals during their final weeks, only about half received community-based healthcare at home.
Purpose: To evaluate whether parametric imaging with contrast material-enhanced ultrasonography (US) is superior to visual assessment for the differential diagnosis of focal liver lesions (FLLs).
Materials And Methods: This study had institutional review board approval, and verbal patient informed consent was obtained. Between August 2005 and October 2008, 146 FLLs in 145 patients (63 women, 82 men; mean age, 62.
Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound.
IEEE Trans Ultrason Ferroelectr Freq Control
November 2010
The differentiation between benign and malignant focal liver lesions plays an important role in diagnosis of liver disease and therapeutic planning of local or general disease. This differentiation, based on characterization, relies on the observation of the dynamic vascular patterns (DVP) of lesions with respect to adjacent parenchyma, and may be assessed during contrast-enhanced ultrasound imaging after a bolus injection. For instance, hemangiomas (i.
View Article and Find Full Text PDFA recombinant rubella virus E1 (rE1) glycoprotein was produced and some of its chemical and immunological features were characterized. Two animal models were then used to establish that the rE1 glycoprotein and rubella virus particles shared antigenic and immunogenic properties. In the first one, sera from rE1 glycoprotein-immunized BALB/c mice neutralized in vitro rubella virus infection.
View Article and Find Full Text PDFA chemokine binding assay on whole cells was developed using biotinylated synthetic CCL22 as a model ligand. CCL22 analogues were produced by a chemical route, resulting in > 97% homogeneous and defined polypeptides. First, the 5 biotinylated CCL22 analogues synthesized were captured by agarose-immobilized streptavidin, indicating that the biotin molecules introduced in positions G1, K27, K49, K61, and K66 of CCL22 were accessible for binding.
View Article and Find Full Text PDF